Pure red cell aplasia induced by FK506. 1996

S Suzuki, and Y Osaka, and I Nakai, and T Yasumura, and Y Omori, and N Yamagata, and C Shimazaki, and T Oka
Second Department of Surgery, Kyoto Prefectural University of Medicine, Japan.

UI MeSH Term Description Entries
D007166 Immunosuppressive Agents Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. Immunosuppressant,Immunosuppressive Agent,Immunosuppressants,Agent, Immunosuppressive,Agents, Immunosuppressive
D008297 Male Males
D012010 Red-Cell Aplasia, Pure Suppression of erythropoiesis with little or no abnormality of leukocyte or platelet production. Aplasia Pure Red Cell,Erythrocyte Aplasia,Pure Red-Cell Aplasia,Aplasia, Erythrocyte,Aplasia, Pure Red-Cell,Aplasias, Erythrocyte,Erythrocyte Aplasias,Pure Red Cell Aplasia,Pure Red-Cell Aplasias,Red Cell Aplasia, Pure,Red-Cell Aplasias, Pure
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D016559 Tacrolimus A macrolide isolated from the culture broth of a strain of Streptomyces tsukubaensis that has strong immunosuppressive activity in vivo and prevents the activation of T-lymphocytes in response to antigenic or mitogenic stimulation in vitro. Anhydrous Tacrolimus,FK-506,FK506,FR-900506,Prograf,Prograft,Tacrolimus Anhydrous,Anhydrous, Tacrolimus,FK 506,FR 900506,FR900506,Tacrolimus, Anhydrous

Related Publications

S Suzuki, and Y Osaka, and I Nakai, and T Yasumura, and Y Omori, and N Yamagata, and C Shimazaki, and T Oka
August 2016, Clinical kidney journal,
S Suzuki, and Y Osaka, and I Nakai, and T Yasumura, and Y Omori, and N Yamagata, and C Shimazaki, and T Oka
June 1988, The American journal of medicine,
S Suzuki, and Y Osaka, and I Nakai, and T Yasumura, and Y Omori, and N Yamagata, and C Shimazaki, and T Oka
October 2018, BMJ case reports,
S Suzuki, and Y Osaka, and I Nakai, and T Yasumura, and Y Omori, and N Yamagata, and C Shimazaki, and T Oka
October 1989, The American journal of medicine,
S Suzuki, and Y Osaka, and I Nakai, and T Yasumura, and Y Omori, and N Yamagata, and C Shimazaki, and T Oka
March 2014, Turkish journal of haematology : official journal of Turkish Society of Haematology,
S Suzuki, and Y Osaka, and I Nakai, and T Yasumura, and Y Omori, and N Yamagata, and C Shimazaki, and T Oka
December 2004, Nederlands tijdschrift voor geneeskunde,
S Suzuki, and Y Osaka, and I Nakai, and T Yasumura, and Y Omori, and N Yamagata, and C Shimazaki, and T Oka
November 2000, American journal of hematology,
S Suzuki, and Y Osaka, and I Nakai, and T Yasumura, and Y Omori, and N Yamagata, and C Shimazaki, and T Oka
May 2003, American journal of hematology,
S Suzuki, and Y Osaka, and I Nakai, and T Yasumura, and Y Omori, and N Yamagata, and C Shimazaki, and T Oka
April 2021, British journal of haematology,
S Suzuki, and Y Osaka, and I Nakai, and T Yasumura, and Y Omori, and N Yamagata, and C Shimazaki, and T Oka
January 2019, Southern African journal of HIV medicine,
Copied contents to your clipboard!